Position in MYGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,455,301
+$779,212 QoQ
Shares Held
254,869
+69.6% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 196 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $174,084,919 across 16 Diagnostics & Research names. MYGN ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
267,932 | $47,110,483 | |
| 2 | NTRA |
Natera, Inc.
|
148,901 | $40,419,176 | |
| 3 | A |
Agilent Technologies, Inc.
|
176,837 | $23,489,258 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
38,375 | $20,323,016 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
88,387 | $17,078,136 | |
| 6 | DHR |
Danaher Corp /De/
|
60,943 | $11,608,422 | |
| 7 | LH |
Labcorp Holdings Inc.
|
14,025 | $3,927,000 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
4,707 | $2,359,901 |
All Filings in MYGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,455,301 | 254,869 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $676,089 | 150,242 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,402,230 | 228,005 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,167,890 | 161,534 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $405,004 | 76,272 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $158,116 | 17,826 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||